Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Northwestern University
mi
from
Chicago, IL
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
Behavioral Strategies to Maximize the Efficacy of Pharmacotherapy for Cocaine Dependence: Relapse Prevention With Contingency Management Procedures
Status: Enrolling
Updated:  1/4/2016
University of Texas Health Science Center
mi
from
Houston, TX
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
Behavioral Strategies to Maximize the Efficacy of Pharmacotherapy for Cocaine Dependence: Relapse Prevention With Contingency Management Procedures
Status: Enrolling
Updated: 1/4/2016
University of Texas Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Status: Enrolling
Updated:  1/5/2016
National Institue Of Fitness and Sport
mi
from
Indianapolis, IN
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Status: Enrolling
Updated: 1/5/2016
National Institue Of Fitness and Sport
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Caffeine and Cocaine
Experiment 1: Adenosine Receptor A2A Antagonists and Cocaine Dependence
Status: Enrolling
Updated:  1/5/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Caffeine and Cocaine
Experiment 1: Adenosine Receptor A2A Antagonists and Cocaine Dependence
Status: Enrolling
Updated: 1/5/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma
A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma
Status: Enrolling
Updated:  1/5/2016
Alameda County Medical Center
mi
from
Oakland, CA
Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma
A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma
Status: Enrolling
Updated: 1/5/2016
Alameda County Medical Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Contraceptive Hormones and Women With Cystic Fibrosis
Contraceptive Hormones and Women With Cystic Fibrosis: Satisfaction and Effects on Disease
Status: Enrolling
Updated:  1/6/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Contraceptive Hormones and Women With Cystic Fibrosis
Contraceptive Hormones and Women With Cystic Fibrosis: Satisfaction and Effects on Disease
Status: Enrolling
Updated: 1/6/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Novel Technique for Face Mask Ventilation
Novel Technique for Face Mask Ventilation
Status: Enrolling
Updated:  1/7/2016
Rutgers RBHS Newark -DOC
mi
from
Newark, NJ
Novel Technique for Face Mask Ventilation
Novel Technique for Face Mask Ventilation
Status: Enrolling
Updated: 1/7/2016
Rutgers RBHS Newark -DOC
mi
from
Newark, NJ
Click here to add this to my saved trials
A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma
Status: Enrolling
Updated:  1/7/2016
University of Louisville - Sam Swope Kosair Charities Centre
mi
from
Louisville, KY
A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma
Status: Enrolling
Updated: 1/7/2016
University of Louisville - Sam Swope Kosair Charities Centre
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma
Status: Enrolling
Updated:  1/7/2016
University of Louisville Allergy and Immunology
mi
from
Louisville, KY
A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma
Status: Enrolling
Updated: 1/7/2016
University of Louisville Allergy and Immunology
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma
Status: Enrolling
Updated:  1/7/2016
University of Louisville Pediatric Pulmonology
mi
from
Louisville, KY
A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma
Status: Enrolling
Updated: 1/7/2016
University of Louisville Pediatric Pulmonology
mi
from
Louisville, KY
Click here to add this to my saved trials
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated:  1/8/2016
Medical Center of Aurora
mi
from
Aurora, CO
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated: 1/8/2016
Medical Center of Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated:  1/8/2016
Rose Medical Center
mi
from
Denver, CO
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated: 1/8/2016
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated:  1/8/2016
St. Anthony Hospital
mi
from
Lakewood, CO
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated: 1/8/2016
St. Anthony Hospital
mi
from
Lakewood, CO
Click here to add this to my saved trials
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated:  1/8/2016
Swedish Medical Center
mi
from
Englewood, CO
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated: 1/8/2016
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated:  1/8/2016
University of Colorado Denver
mi
from
Aurora, CO
Treatment of Critical Illness Polyneuromyopathy
Randomized Trial of Intensive Physical Therapy for Patients With Acute Respiratory Failure
Status: Enrolling
Updated: 1/8/2016
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome
Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome
Status: Enrolling
Updated:  1/8/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome
Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome
Status: Enrolling
Updated: 1/8/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Reproductive Aging and Obstructive Sleep Apnea
Reproductive Aging and Obstructive Sleep Apnea
Status: Enrolling
Updated:  1/8/2016
LA Biomedical Research Institute
mi
from
Torrance, CA
Reproductive Aging and Obstructive Sleep Apnea
Reproductive Aging and Obstructive Sleep Apnea
Status: Enrolling
Updated: 1/8/2016
LA Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity Resp Insufficiency
Pilot Study: Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity of Respiratory Insufficiency
Status: Enrolling
Updated:  1/11/2016
Baylor University Medical Center
mi
from
Dallas, TX
Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity Resp Insufficiency
Pilot Study: Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity of Respiratory Insufficiency
Status: Enrolling
Updated: 1/11/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated:  1/11/2016
National Jewish Hospital
mi
from
Denver, CO
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated: 1/11/2016
National Jewish Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated:  1/11/2016
UNC Chapel Hill
mi
from
CHapel Hill, NC
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated: 1/11/2016
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated:  1/11/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated: 1/11/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated:  1/11/2016
Medical University of South Carolina
mi
from
Charleston, SC
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated: 1/11/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated:  1/11/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated: 1/11/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated:  1/11/2016
Children's Hospital Boston
mi
from
Boston, MA
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.
Status: Enrolling
Updated: 1/11/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Safety Study of Nebivolol for COPD Patients
Nebivolol in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Safety Study of Nebivolol for COPD Patients
Nebivolol in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
205.440.1015 Boehringer Ingelheim Investigational Site
mi
from
Jasper, AL
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
205.440.1015 Boehringer Ingelheim Investigational Site
mi
from
Jasper, AL
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
205.452.01011 Boehringer Ingelheim Investigational Site
mi
from
Clearwater, FL
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
205.452.01011 Boehringer Ingelheim Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
1268.17.01045 Boehringer Ingelheim Investigational Site
mi
from
Deland, FL
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
1268.17.01045 Boehringer Ingelheim Investigational Site
mi
from
Deland, FL
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
205.452.01060 Boehringer Ingelheim Investigational Site
mi
from
Winter Park, FL
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
205.452.01060 Boehringer Ingelheim Investigational Site
mi
from
Winter Park, FL
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
205.452.01047 Boehringer Ingelheim Investigational Site
mi
from
Austell, GA
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
205.452.01047 Boehringer Ingelheim Investigational Site
mi
from
Austell, GA
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Albuquerque, NM
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Charlotte, NC
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
1222.29.11003 Boehringer Ingelheim Investigational Site
mi
from
Raleigh, NC
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
1222.29.11003 Boehringer Ingelheim Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Columbus, OH
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
1222.25.25014 Boehringer Ingelheim Investigational Site
mi
from
Seneca, SC
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
1222.25.25014 Boehringer Ingelheim Investigational Site
mi
from
Seneca, SC
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
1160.129.32082 Boehringer Ingelheim Investigational Site
mi
from
Knoxville, TN
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
1160.129.32082 Boehringer Ingelheim Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Richmond, VA
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/11/2016
Boehringer Ingelheim Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF
Detection of Pseudomonas. Aeruginosa in the Airways of Patients With Cystic Fibrosis Using of Aerosolized 13C-urea
Status: Enrolling
Updated:  1/12/2016
University of New Mexico
mi
from
Albuquerque, NM
Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF
Detection of Pseudomonas. Aeruginosa in the Airways of Patients With Cystic Fibrosis Using of Aerosolized 13C-urea
Status: Enrolling
Updated: 1/12/2016
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Artificial Neural Network Directed Therapy of Severe Obstructive Sleep Apnea
Artificial Neural Network Directed Therapy of Severe Obstructive Sleep Apnea
Status: Enrolling
Updated:  1/12/2016
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Artificial Neural Network Directed Therapy of Severe Obstructive Sleep Apnea
Artificial Neural Network Directed Therapy of Severe Obstructive Sleep Apnea
Status: Enrolling
Updated: 1/12/2016
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients
Post-Operative Infusion of Low-Dose Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients: A Randomized, Double-Blind, Controlled Pilot Study
Status: Enrolling
Updated:  1/12/2016
Baylor University Medical Center - Department of Anesthesiology
mi
from
Dallas, TX
Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients
Post-Operative Infusion of Low-Dose Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients: A Randomized, Double-Blind, Controlled Pilot Study
Status: Enrolling
Updated: 1/12/2016
Baylor University Medical Center - Department of Anesthesiology
mi
from
Dallas, TX
Click here to add this to my saved trials
A Clinical Trial for CTD-ILD Treatment
Clinical Trial of Oral Medication for CTD-ILD Treatment
Status: Enrolling
Updated:  1/14/2016
University of Michigan
mi
from
Ann Arbor, MI
A Clinical Trial for CTD-ILD Treatment
Clinical Trial of Oral Medication for CTD-ILD Treatment
Status: Enrolling
Updated: 1/14/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study
CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study
Status: Enrolling
Updated:  1/14/2016
State University of New York at Buffalo
mi
from
Buffalo, NY
CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study
CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study
Status: Enrolling
Updated: 1/14/2016
State University of New York at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Combination Paclitaxel, Carboplatin and Temozolomide
Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies.
Status: Enrolling
Updated:  1/15/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Combination Paclitaxel, Carboplatin and Temozolomide
Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies.
Status: Enrolling
Updated: 1/15/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Muscle Atrophy in Patients With Severe Sepsis
Muscle Atrophy in Patients With Severe Sepsis
Status: Enrolling
Updated:  1/15/2016
The Ohio State University Medical Center - University Hospital
mi
from
Columbus, OH
Muscle Atrophy in Patients With Severe Sepsis
Muscle Atrophy in Patients With Severe Sepsis
Status: Enrolling
Updated: 1/15/2016
The Ohio State University Medical Center - University Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study to Evaluate the Effect of Mechanical Ventilation on the Inferior Vena Cava Collapsibility Index
A Prospective Pilot Study to Evaluate the Effect of Mechanical Ventilation on the Inferior Vena Cava Collapsibility Index
Status: Enrolling
Updated:  1/15/2016
Ohio State University
mi
from
Columbus, OH
A Study to Evaluate the Effect of Mechanical Ventilation on the Inferior Vena Cava Collapsibility Index
A Prospective Pilot Study to Evaluate the Effect of Mechanical Ventilation on the Inferior Vena Cava Collapsibility Index
Status: Enrolling
Updated: 1/15/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Status: Enrolling
Updated:  1/18/2016
Scripps Clinic
mi
from
San Diego, CA
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Status: Enrolling
Updated: 1/18/2016
Scripps Clinic
mi
from
San Diego, CA
Click here to add this to my saved trials
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Status: Enrolling
Updated:  1/18/2016
Kansas City Allergy and Asthma Associates
mi
from
Overland Park, KA
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Status: Enrolling
Updated: 1/18/2016
Kansas City Allergy and Asthma Associates
mi
from
Overland Park, KA
Click here to add this to my saved trials